OIG 2015 Work Plan, Part 1: Do Fewer Projects Mean a Sharper Focus?
January 8, 2015
Members of Foley’s health care industry team contributed an article to Compliance Today, “OIG 2015 Work Plan, Part 1: Do Fewer Projects Mean a Sharper Focus?,” that appeared in the January 2015 issue. The article provided an overview of major enforcement projects in the U.S. Department of Health and Human Services’ Office of Inspector General’s (OIG) 2015 Work Plan. The article is the first part of a two-part article and addresses Medicare Parts A and B.
Author(s)
Related Insights
April 14, 2026
Health Care Law Today
FDA Clarifies Policies for Pharmacy Compounders of GLP-1 Products
On April 1, 2026,the U.S. Food & Drug Administration (FDA) issued a statement clarifying its compliance policy on the conditions that must be met for compounded drugs to qualify for the exemptions under Sections 503A and 503B of the Federal Food, Drug, and Cosmetic Act (FD&C Act).
April 14, 2026
Foley Career Perspectives
Trust Your Instincts: Susan Pravda on Leadership, Relationships, and Resilience
Foley partner Susan Pravda is a business lawyer focused on mergers and acquisitions, venture capital, initial public offerings, and related securities transactions and is head of Foley’s Health Care & Life Sciences Sector. She also serves as the firm’s chief strategic talent acquisition partner.
April 14, 2026
Blogs
When to Litigate and When to Walk Away
Clients faced with defending or initiating litigation often begin with the question: “Can we win?” The question sounds simple enough, and if the law is favorable, the instinctive answer might be “yes.” But “winning” in court doesn’t happen, and can’t be evaluated, in a vacuum. In reality, the odds of success in litigation depend not only on the law and facts of the case but also on any business constraints and potential consequences.